BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors
Clinical trial NCT01938846 · COMPLETED
Trial details
- NCT number
- NCT01938846
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-05
- Primary completion
- 2016-07-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.